Springer Nature
Browse

sorry, we can't preview this file

40345_2018_122_MOESM2_ESM.docx (19.97 kB)

MOESM2 of Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Download (19.97 kB)
journal contribution
posted on 2018-06-10, 05:00 authored by Joseph Calabrese, Na Jin, Brian Johnson, Pedro Such, Ross Baker, Jessica Madera, Peter Hertel, Jocelyn Ottinger, Joan Amatniek, Hiroaki Kawasaki
Additional file 2: Table S2. Change from baseline to week 52 in extrapyramidal symptoms scales during AOM 400 maintenance phase.

Funding

Otsuka Pharmaceutical Development & Commercialization, Inc.

History